Page 16 - Shimadzu SALD-7500nano
P. 16

C060-E009B


            Aggregation Analysis System for Biopharmaceuticals                                                         SALD-7500nano
            Aggregates Sizer

            The Aggregation Analysis System for Biopharmaceuticals is created by adding a
            special option to the SALD-7500nano Nano Particle Size Analyzer. It permits the
            quantitative evaluation of sub-visible particles (SVP) in the sub-visible region
            (100 nm to 10 µm). Despite the ability of sub-visible particles (SVP) to cause                                               Nano Particle Size Analyzer
            fatal side effects in humans, such as anaphylaxis, they have been little studied                                             SALD-7500nano
            and no analytical method has been established for them. This system offers the
            following three features.


             1  Quantitatively evaluates SVP range aggregate concentrations
               The Aggregates Sizer is able to measure aggregates of a wide range of particles sizes, from 7 nm to 800 µm, as part of a particle size distribution
               (displayed with particle quantities totaling 100 %). Furthermore, aggregate concentrations in the SVP (sub-visible particle) range, from 100 nm to
               10 µm, can be evaluated quantitatively (in terms of µg/mL or number/mL).

                                           Evaluation range of particle size: 40 nm to 20 µm
                                            Concentration display range: 40 nm to 20 µm


             2  Measures aggregates with high sensitivity
               The Aggregates Sizer is over ten times more sensitive than Shimadzu's previous SALD series (SALD-7100) particle size analyzers. This means that even
               micro sample quantities can be measured accurately using disposable cells for 0.4 mL sample quantities.

             3  Quantitatively evaluates aggregation processes at intervals as short as one second
               Changes (sizes and quantities) in aggregates can be confirmed quantitatively as a concentration (unit: µg/mL) at intervals as short as one second.
               This allows observing the status at various intermediate stages, not just at two stages, before and after such changes, which allows evaluating rates of
               change. Using a batch cell (5 mL sample capacity), aggregation processes can be observed as samples are mechanically stimulated.


             4  Evaluates effect of temperature on aggregation process
               Aggregates Sizer TC temperature control system can evaluate protein aggregates under a constant temperature (20 °C to 42 °C). It enables the
               evaluation of protein aggregation depending on the temperature.






            *1: Windows is a registered trademark of Microsoft Corporation in the United States and other countries.
            *2: Other company names and product names mentioned in this document are registered trademarks or trademarks of their respective companies.
            *3: The TM and R symbols are omitted in this document.



















                                               Company names, product/service names and logos used in this publication are trademarks and trade names of Shimadzu Corporation or its
                                               affiliates, whether or not they are used with trademark symbol “TM” or “®”.
                                               Third-party trademarks and trade names may be used in this publication to refer to either the entities or their products/services. Shimadzu
                                               disclaims any proprietary interest in trademarks and trade names other than its own.
                                               For Research Use Only. Not for use in diagnostic procedures.
                                               The contents of this publication are provided to you “as is” without warranty of any kind, and are subject to change without notice. Shimadzu
                                               does not assume any responsibility or liability for any damage, whether direct or indirect, relating to the use of this publication.
       www.shimadzu.com/an/                                                                        © Shimadzu Corporation, 2015
                                                                                               Printed in Japan 3655-07501-15AIK
   11   12   13   14   15   16